These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10125081)

  • 41. Why managed competition cannot be enacted.
    Glaser W
    Health Aff (Millwood); 1993; 12(3):277-8. PubMed ID: 8244244
    [No Abstract]   [Full Text] [Related]  

  • 42. A model for regulating managed competition.
    Glaudemans J
    J Health Care Benefits; 1994; 3(3):16-23. PubMed ID: 10131211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Challenges for managed competition from chronic illness.
    Schlesinger M; Mechanic D
    Health Aff (Millwood); 1993; 12 Suppl():123-37. PubMed ID: 8477927
    [No Abstract]   [Full Text] [Related]  

  • 44. Paul Ellwood and the Jackson Hole Group--a close-up. Interview by John Herrmann.
    Ellwood P
    Health Syst Rev; 1993; 26(2):18-9. PubMed ID: 10124551
    [No Abstract]   [Full Text] [Related]  

  • 45. Key issues in managed competition.
    Shapiro DW
    West J Med; 1994 May; 160(5):434-9. PubMed ID: 8048227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Managed competition, antitrust, and the Clinton health reform plan: too modest a proposal.
    Kopit WG
    Healthspan; 1993 Nov; 10(10):21-4. PubMed ID: 10130836
    [No Abstract]   [Full Text] [Related]  

  • 47. Managed competition is the future of healthcare reform. Interview by Bill Siwicki.
    Cooper J
    Healthc Financ Manage; 1993 Mar; 47(3):20-2. PubMed ID: 10145765
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinton's master plan. Final decisions on health reform: how much it will cost and who pays.
    Dentzer S
    US News World Rep; 1993 May; 114(20):22-4, 26, 28. PubMed ID: 10126358
    [No Abstract]   [Full Text] [Related]  

  • 49. Aggressive regulator or passive price-taker: what role should HIPCs (health insurance purchasing cooperatives) play?
    Wicks EK
    J Am Health Policy; 1993; 3(4):21-5. PubMed ID: 10127493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Florida adopts a managed competition state system.
    Health Care Strateg Manage; 1993 Jun; 11(6):11. PubMed ID: 10126418
    [No Abstract]   [Full Text] [Related]  

  • 51. Commentary: measuring the candidates on health care.
    Enthoven AC
    N Engl J Med; 1992 Sep; 327(11):807-9. PubMed ID: 1501658
    [No Abstract]   [Full Text] [Related]  

  • 52. Living with capitation. Experts look at challenges of setting a prepaid rate.
    Blankenau R
    Hospitals; 1993 Apr; 67(7):30-1. PubMed ID: 8458621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sunshine state pushes managed competition reforms.
    Kent C
    J Am Health Policy; 1993; 3(2):61-3. PubMed ID: 10126984
    [No Abstract]   [Full Text] [Related]  

  • 54. Mayors, governors, business leaders in accord on managed competition, split on mandates, global budgets.
    Weissenstein E
    Mod Healthc; 1992 Dec 21-28; 22(51):13. PubMed ID: 10122777
    [No Abstract]   [Full Text] [Related]  

  • 55. What will healthcare reform cost?
    White JH
    Health Prog; 1993 May; 74(4):15-7, 31. PubMed ID: 10125357
    [No Abstract]   [Full Text] [Related]  

  • 56. Medical group practice and President Clinton's health reform proposals.
    Weil TP
    Med Group Manage J; 1993; 40(2):54-66; discussion 68-9. PubMed ID: 10124709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The marketplace in health care reform. The demographic limitations of managed competition.
    Kronick R; Goodman DC; Wennberg J; Wagner E
    N Engl J Med; 1993 Jan; 328(2):148-52. PubMed ID: 8416437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Commentary: politics and the health care system.
    Reinhardt UE
    N Engl J Med; 1992 Sep; 327(11):809-11. PubMed ID: 1501659
    [No Abstract]   [Full Text] [Related]  

  • 59. Medical technology meets managed competition.
    Durenberger D; Foote SB
    J Am Health Policy; 1993; 3(3):23-8. PubMed ID: 10125731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The fraud and abuse statute in an evolving health care marketplace: life in the health care speakeasy.
    Blumstein JF
    Am J Law Med; 1996; 22(2-3):205-31. PubMed ID: 8862242
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.